首页> 中文期刊> 《国际感染杂志(电子版)》 >Chronic Liver Failure after Treatment with Infliximab for Ankylosing Spondylitis in a Patient with Hepatitis B

Chronic Liver Failure after Treatment with Infliximab for Ankylosing Spondylitis in a Patient with Hepatitis B

         

摘要

A 50-year-old man with ankylosing spondylitis was treated successfully with inlfiximab, who was also a HBV carrier for about twenty-ifve years. After injection with inlfiximab for four times, he developed jaundice and HBV DNA was detectable in serum. Serum aminotransferase and total bilirubin levels were higher than normal. Then he was hospitalized and treated with entacavir and Chinese herb medicine. But his liver damage aggravated and was diagnosed as acute on chronic liver failure. Finally, liver transplantation was carried out and he was cured successfully.

著录项

  • 来源
    《国际感染杂志(电子版)》 |2013年第2期|84-87|共4页
  • 作者单位

    Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;

    Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;

    Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;

    Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;

    Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号